Completed PHASE2 INTERVENTIONAL 2-arm NCT00089180

T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant

A Phase IIb Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Topical Bacteriophage T4 Endonuclease V in Renal Allograft Recipients With a History of Non-melanoma Skin Cancer

Sponsor: National Cancer Institute (NCI)

Conditions Actinic Keratosis Basal Cell Carcinoma of the Skin Recurrent Skin Cancer Squamous Cell Carcinoma of the Skin

Interventions laboratory biomarker analysis liposomal T4N5 lotion placebo

Updated 5 times since 2017 Last updated: Dec 3, 2015 Started: Mar 31, 2004 Primary completion: Jan 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00089180, this PHASE2 trial focuses on Actinic Keratosis and Basal Cell Carcinoma of the Skin and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 5 times since 2004, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute (NCI)

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Birmingham, United States